Cargando…
Levodopa-Responsive Chorea: A Review
BACKGROUND: Chorea is one of the disabling movement disorders, and the number of drugs which can treat this disorder effectively is limited. Tetrabenazine and deutetrabenazine are the two drugs approved by the US-FDA for the treatment of chorea associated with HD. Levodopa can improve chorea in some...
Autores principales: | Farrenburg, Mark, Gupta, Harsh V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061510/ https://www.ncbi.nlm.nih.gov/pubmed/32189864 http://dx.doi.org/10.4103/aian.AIAN_221_19 |
Ejemplares similares
-
Levodopa-Carbidopa Intestinal Gel Pharmacokinetics: Lower Variability than Oral Levodopa-Carbidopa
por: Othman, Ahmed A., et al.
Publicado: (2017) -
A sydenham chorea attack associated with COVID-19 infection
por: Yüksel, Merve Feyza, et al.
Publicado: (2021) -
Paraneoplastic Chorea Managed with Intravenous Amantadine
por: Doher, Nicholas, et al.
Publicado: (2019) -
Levodopa responsive gait dynamics in OFF- and ONOFF-state freezing of gait in Parkinson’s disease
por: Virmani, Tuhin, et al.
Publicado: (2023) -
Impact of Levodopa in Lung Functions in Patients with Parkinson Disease
por: Tandon, Medha, et al.
Publicado: (2020)